Skip to main content
Log in

Distribution of estrogen and progesterone receptors in healthy tissue adjacent to breast lesions at various stages — Immunohistochemical study of 107 cases

  • Report
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Summary

The purpose of this study was to determine the distribution of ER+ (estrogen receptor) and PR+ (progesterone receptor) epithelial cells in normal mammary tissue or in tissue in contact with or involved in benign or malignant processes. Three important findings emerged from this study.

First, a true dissociation was observed between ER+ and PR+ cells in mammary tissue. In premenopausal women some cells express only progesterone receptors. In premenopausal normal tissue, regardless of the menstrual cycle status, 6% of cells are ER+ and 29% PR+.

Second, during the menstrual cycle the percentage of positive cells varies. This finding would indicate a change in cell recruitment rather than in intracellular levels.

Finally, specific changes in the proportion of positive cells in normal tissue in contact with epithelial proliferations were noted. This finding suggests the possibility of either a diffusible factor or a cellular pathological process spreading beyond areas displaying morphological changes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Kouyoumdjian JC: Etude des récepteurs des hormones stéroides dans la glande mammaire normale et dans les mastopathies bénignes. Bull Cancer 73: 120–123, 1986

    PubMed  Google Scholar 

  2. Jacquemier J, Charpin C, Martin PM: Etude immunohistochimique par anticorps monoclonal (H222 SP) des récepteurs oestrogéniques: Corrélations avec l'analyse biochimique (par radio-ligand) pour 115 carcinomes mammaires. Bull Cancer 73: 107–119, 1986

    PubMed  Google Scholar 

  3. Fournier S, Prudhomme JF, Martin PM, Kuttenn F: Récepteurs des hormones stéroides dans les mastopathies bénignes. Path Biol 31: 767–773, 1983

    Google Scholar 

  4. Silva JS, Georgiade GS, Dilley WG, Mc Carty KS, Wells SA, Mc Carty KS: Menstrual cycle-dependent variations of breast cyst fluid proteins and sex steroid receptors in the normal human breast. Cancer 51: 1297–1302, 1983

    PubMed  Google Scholar 

  5. Jacquemier J, Gandilhon PH, Charpin C, Pourreau-Schneider N, Hassoun J, Martin PM: Tissu mammaire: récepteurs estrogéniques. Analyse immunohistochimique et biochimique du tissu normal, hyperplasique et du carcinome in situ. A propos de 86 cas. Bull Cancer 74: 129–149, 1987

    PubMed  Google Scholar 

  6. Perrot-Applanat M, Groyer-Picard MT, Lorenzo, Jolivet A, Thu Vu Hai M, Pallud C, Spyratos F, Milgrom E: Immunocytochemical study with monoclonal antibodies to progesterone receptor in human breast tumors. Cancer Res 47: 2652–2661, 1987

    PubMed  Google Scholar 

  7. Clark GM, McGuire WL: Prognostic factors in primary breast cancer. Breast Cancer Res Treat 3: 69–72, 1983

    Google Scholar 

  8. McGuire WL: Prognostic factors for recurrence and survival in human breast cancer. Breast Cancer Res Treat 10: 5–9, 1987

    PubMed  Google Scholar 

  9. Kuttenn F, Fournier S, Durand JC, Mauvais-Jarvis P: Estradiol and progesterone receptors in human breast fibroadenomas. J Clin Endocrinol Metab 52: 1225, 1981

    PubMed  Google Scholar 

  10. Clark JH, Hsueh AJW, Peck EJ: Regulation of estrogen receptor replienishment by progesterone. Ann NY Acad Sci 286: 161–179, 1977

    PubMed  Google Scholar 

  11. Horwitz KB, McGuire WL, Pearson OH: Predicting response to endocrine therapy in human breast cancer: A hypothesis. Science 189: 726–727, 1975

    PubMed  Google Scholar 

  12. Magdelenat H, Pertuiset BF, Poisson M: Progestin and oestrogen receptors in meningiomas. Biochemical characterization, clinical and pathological correlations in 42 cases. Acta Neurochir 64: 199–213, 1982

    Google Scholar 

  13. Tilzer LL, Plapp FC, Evans JP, Stone D, Alward K: Steroid receptor proteins in human meningiomas. Cancer 49: 633–636, 1982

    PubMed  Google Scholar 

  14. Poisson M: Sex steroid receptors in human meningiomas. Clin Neuropharmacol 7: 320–324, 1984

    PubMed  Google Scholar 

  15. Horwitz KB, Mockus MB, Lessey BA: Variant T47D human breast cancer cells with high progesterone receptor levels despite estrogen and antiestrogen resistance. Cell 28: 633–642, 1982

    PubMed  Google Scholar 

  16. Hissom JR, Moore MR: Progestin effects on growth in the human breast cancer cell line T47D Possible therapeutic implications. Biochem Biophys Res Commun 145: 706–711, 1987

    PubMed  Google Scholar 

  17. Kiang DT, Kollander R: Breast cancers negative for estrogen receptor but positive for progesterone receptor. A true entity? J Clin Oncol 5: 662–666, 1987

    PubMed  Google Scholar 

  18. King RJB: An overview of the steroid receptor machinery. In: Nunez J, Dumont JE, King RJB (eds) Hormones and Cell Regulation. (Colloque INSERM 139). John Libbey, London, 1986, pp 55–67

    Google Scholar 

  19. Sheridan PJ, Buchanen JM, Anselmo VC, Martin PM: Equilibrium: The intracellular distribution of steroid receptors. Nature 282: 579–582, 1979

    PubMed  Google Scholar 

  20. Sheridan PJ, Martin PM, Blum K: Steroid hormone dynamics: A function of cellular equilibrium. In: Sheridan PJ, Blum K, Trachtenberg MC (eds) Steroid Receptors and Disease: Cancer Autoimmune, Bone, and Circulatory Disorders. M. Dekker, New York, 1988, pp 49–70

    Google Scholar 

  21. Jacquemier J, Rolland PH, Vague D, Lieutaud R, Spitalier JM, Martin PM: Relationships between steroid receptor and epithelial cell proliferation in benign fibrocystic disease of the breast. Cancer 49: 2534–2536, 1982

    PubMed  Google Scholar 

  22. Giani C, D'Amore E, Delarue JC, Mouriesse H, May-Levin F, Sancho-Garnier H, Breccia M, Contesso G: Estrogen and progesterone receptors in benign breast tumors and lesions: relationship with histological and cytological features. Int J Cancer 37: 7–10, 1986

    PubMed  Google Scholar 

  23. Hawkins RA, Tesdale AL, Ferguson WA, Going JJ: Oestrogen receptor activity an intraduct and invasive breast carcinomas. Breast Cancer Res Treat 9: 129–133, 1987

    PubMed  Google Scholar 

  24. Mignot L, Espie M, de Roquancourt A, Gorins A: Les récepteurs hormonaux et les lésions pré-cancéreuses du sein. Path Biol 31: 761–764, 1983

    Google Scholar 

  25. Petersen OW, Hoyer PE, Van Deurs B: Frequency and distribution of estrogen receptor-positive cells in normal, nonlacting human breast tissue. Cancer Res 47: 5748–5751, 1987

    PubMed  Google Scholar 

  26. Miller WR, Hawkins RA, Forrest APM: Significance of aromatase activity in human breast cancer. Cancer Res 42: 3365–3368, 1982

    Google Scholar 

  27. O'Neill JS, Miller WR: Aromatase activity in breast adipose tissue from women with benign and malignant breast diseases. Br J Cancer 56: 601–604, 1987

    PubMed  Google Scholar 

  28. Arteaga CL, Tandon AK, Von Hoff DD, Osborne CK: Transforming growth factor β: Potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells. Cancer Res 48: 3898–3904, 1988

    PubMed  Google Scholar 

  29. Fabbro D, Küng W, Roos W, Regazzi R, Eppenberger U: Epidermal growth factor binding and protein kinase C activities in human breast cancer cell lines: possible quantitative relationship. Cancer Res 46: 2720–2725, 1986

    PubMed  Google Scholar 

  30. Nicholson S, Sainsbury JRC, Needham GK, Chambers P, Farndon JR, Harris AL: Quantitative assays of epidermal growth factor receptor in human breast cancer: cut-off points of clinical relevance. Int J Cancer 42: 36–41, 1988

    PubMed  Google Scholar 

  31. Pekonen F, Partanen S, Mäkinen T, Rutanen EM: Receptors for epidermal growth factor and insulin-like growth factor I and their relation to steroid receptors in human breast cancer. Cancer Res 48: 1343–1347, 1988

    PubMed  Google Scholar 

  32. Berthois Y, Dong XF, Martin PM: Regulation of epidermal growth factor-receptor by estrogen and antiestrogen in the human breast cancer cell line MCF-7 (in press)

  33. Lippman ME, Dickson RB, Bates S, Knabbe C, Huff K, Swain S, Mc Manawas M, Bronzert D, Kasid A, Gelmann E: Autocrine and paracrine growth regulation of human breast cancer. Breast Cancer Res Treat 7: 59–70, 1986

    PubMed  Google Scholar 

  34. Wilding G, Lippman ME, Dickson RB: The cellular response of human breast cancer to estrogen. In: Hankins WD, Buett D (eds) Progress in clinical and biological research. Alan R. Liss, New York, 1988, 262, pp 181–196

    Google Scholar 

  35. Wellings SR, Jensen HM: On the origin and progression of ductal carcinoma in the human breast. J Nat Cancer Inst 50 1111–1115, 1973

    PubMed  Google Scholar 

  36. Rudland PS: Stem cells and the development of mammary cancers in experimental rats and in humans. Cancer Metast Rev 6: 55–83, 1987

    Google Scholar 

  37. Russo J, Russo I: Biology of disease. Biological and molecular bases of mammary carcinogenesis. Lab Invest 57: 112–137, 1987

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jacquemier, J.D., Hassoun, J., Torrente, M. et al. Distribution of estrogen and progesterone receptors in healthy tissue adjacent to breast lesions at various stages — Immunohistochemical study of 107 cases. Breast Cancer Res Tr 15, 109–117 (1990). https://doi.org/10.1007/BF01810783

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01810783

Key words

Navigation